Cargando…
Exploitation of Neisseria meningitidis Group B OMV Vaccines Against N. gonorrhoeae to Inform the Development and Deployment of Effective Gonorrhea Vaccines
Have potential clues to an effective gonorrhea vaccine been lurking in international disease surveillance data for decades? While no clinically effective vaccines against gonorrhea have been developed we present direct and indirect evidence that a vaccine is not only possible, but may already exist....
Autores principales: | Petousis-Harris, Helen, Radcliff, Fiona J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6465565/ https://www.ncbi.nlm.nih.gov/pubmed/31024540 http://dx.doi.org/10.3389/fimmu.2019.00683 |
Ejemplares similares
-
The comparative population genetics of Neisseria meningitidis and Neisseria gonorrhoeae
por: Vigué, Lucile, et al.
Publicado: (2019) -
Genomic Diversity and Chromosomal Rearrangements in Neisseria gonorrhoeae and Neisseria meningitidis
por: Shaskolskiy, Boris, et al.
Publicado: (2022) -
Potential impact of vaccination against Neisseria meningitidis on Neisseria gonorrhoeae in the United States: Results from a decision-analysis model
por: Régnier, Stéphane A, et al.
Publicado: (2014) -
Vaccine development against Neisseria meningitidis
por: Vogel, Ulrich, et al.
Publicado: (2011) -
Distinct Patterns of Host Adherence by Neisseria gonorrhoeae Isolated from Experimental Gonorrhea
por: He, Yingxia, et al.
Publicado: (2021)